For a list of projects in Uganda: click here
Recent and Ongoing Projects
Many grant-supported research activities at Makerere University emphasize a multidisciplinary approach to health and disease (e.g., HHV-8 and malignancy; neurobehavioral sequelae of severe malaria; iron deficiency; severe malaria and neurodevelopment; zoonotic sources of human disease outbreaks; neurologic complications of HIV), making Uganda an outstanding partner for Global Health Fellowship training. NPGH projects in the past have focused on complications of malaria (cerebral malaria, malaria and sickle cell anemia), and plasma transfusions for hematological cancer patients.
Established in 1922 as a technical school, Makerere University is one of the oldest Universities in Africa. In 2011, The University became a Collegiate University, consisting of 8 Colleges and 2 Schools operating as semi-autonomous units of the University. Makerere University has had strong research collaborations with UW and UMN since 2002 and 2003, respectively. These institutions currently partner on many different research studies, and also focus on education in HIV and connections between infection and neurodevelopment. The UMN is also engaged in faculty mentor training at Makerere University, and partners closely with the Medical Education Partnership Initative project (MEPI) at Makerere University. The MEPI project aims to increase capacity of health care workers, strengthen medical education and build clinical and research capacity at Makerere University and throughout Uganda. UMN sponsors a 2-week Global Health Institute at Makerere as part of its OneHealth Initiative, focusing on connections between ecology and human health, and the UMN RESPOND project has a center in Uganda which collaborates with the Ugandan Ministry of Health to increase capacity for detecting and responding to disease outbreaks, including zoonotic disease outbreaks.
The Uganda Cancer Institute (UCI) is the only cancer treatment and training facility in Uganda. In Uganda, six out of ten of the most common cancers are due to infectious diseases. Because of its tremendous burden of infection-related cancers, Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers. The UCI is closely affiliated with the Fred Hutchinson Cancer Research Center in Seattle.
By working closely with Ugandan researchers and oncologists, researchers at the UCI/Hutchinson Center Cancer Alliance hope to expand their knowledge of infection-related cancers and improve cancer care in Uganda and at home. The Center developed a three-pronged approach for addressing the needs of cancer patients in Uganda: 1) conduct cutting-edge research in infection-related cancers to better understand the pathogenesis of these diseases in order to develop and test more effective, efficacious and safer treatment and prevention regimens; 2) improve clinical capacity through provision of medical support and revised clinical protocols for those with infectious cancers; and 3) train clinicians and support staff to enhance local human capacity to sustain research and clinical care activities at the site.